Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Normalization of the tumor microenvironment by harnessing vascular and immune modulation to achieve enhanced cancer therapy
Yechan Choi, Keehoon Jung
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 11, pp. 2308-2319
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Targeting cytokine and chemokine signaling pathways for cancer therapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 36
Targeting the tumour vasculature: from vessel destruction to promotion
Sophie Guelfi, Kairbaan Hodivala‐Dilke, Gabriele Bergers
Nature reviews. Cancer (2024) Vol. 24, Iss. 10, pp. 655-675
Closed Access | Times Cited: 18
Advances and Challenges in Targeting TGF-β Isoforms for Therapeutic Intervention of Cancer: A Mechanism-Based Perspective
David Danielpour
Pharmaceuticals (2024) Vol. 17, Iss. 4, pp. 533-533
Open Access | Times Cited: 16
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
Antonino Glaviano, Hannah Lau, Lukas M. Carter, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 2
Emerging role of immunogenic cell death in cancer immunotherapy: Advancing next-generation CAR-T cell immunotherapy by combination
Zhaokai Zhou, Yumiao Mai, Ge Zhang, et al.
Cancer Letters (2024) Vol. 598, pp. 217079-217079
Closed Access | Times Cited: 10
Multi‐Metallic Nanosheets Reshaping Immunosuppressive Tumor Microenvironment through Augmenting cGAS‐STING Innate Activation and Adaptive Immune Responses for Cancer Immunotherapy
Yuxuan Peng, Shuang Liang, Dan Liu, et al.
Advanced Science (2024) Vol. 11, Iss. 38
Open Access | Times Cited: 7
Engineering tumor-oxygenated nanomaterials: advancing photodynamic therapy for cancer treatment
Tingting Zuo, Xiaodie Li, Xuan Ma, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access | Times Cited: 5
Engineered bacteria breach tumor physical barriers to enhance radio-immunotherapy
Yanxiang Zhang, Yue Liu, Tingting Li, et al.
Journal of Controlled Release (2024) Vol. 373, pp. 867-878
Closed Access | Times Cited: 5
Normalization of tumor vasculature by imiquimod: proposal for a new anticancer therapeutic indication for a TLR7 agonist
Jarosz-Biej Magdalena, Czapla Justyna, C Renshaw Joanna, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 3
Open Access
Novel gene manipulation approaches to unlock the existing bottlenecks of CAR-NK cell therapy
Fatemeh Dehghan, Yekta Metanat, Mandana Askarizadeh, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access
A comprehensive prognostic and immune analysis of LAPTM4B in pan-cancer and Philadelphia chromosome-positive acute lymphoblastic leukemia
Hui Zhou, Yuyao Yi, Wei He, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Spatiotemporal metabolomic approaches to the cancer-immunity panorama: a methodological perspective
Yang Xiao, Yongsheng Li, Huakan Zhao
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Clinical Potential of YY1-Hypoxia Axis for Vascular Normalization and to Improve Immunotherapy
Concetta Meo, Filomena de Nigris
Cancers (2024) Vol. 16, Iss. 3, pp. 491-491
Open Access | Times Cited: 3
Unlocking the potential: Targeting metabolic pathways in the tumor microenvironment for Cancer therapy
Siyuan Jia, Ann M. Bode, Xue Chen, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189166-189166
Closed Access | Times Cited: 3
ZBTB46 coordinates angiogenesis and immunity to control tumor outcome
Ashraf Ul Kabir, Carisa Zeng, Madhav Subramanian, et al.
Nature Immunology (2024) Vol. 25, Iss. 9, pp. 1546-1554
Closed Access | Times Cited: 3
Microphysiological systems as models for immunologically ‘cold’ tumors
Daniela Gaebler, Stephanie J. Hachey, Christopher C.W. Hughes
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 2
Pericytes: jack-of-all-trades in cancer-related inflammation
Marianna Moro, Federica Carolina Balestrero, Ambra A. Grolla
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Strategies to Overcome Hurdles in Cancer Immunotherapy
Ji‐Hyun Kim, B.J. Lee, Sehoon Moon, et al.
Biomaterials Research (2024) Vol. 28
Open Access | Times Cited: 2
Transformative Impact of Nanocarrier‐Mediated Drug Delivery: Overcoming Biological Barriers and Expanding Therapeutic Horizons
Minhye Kim, Myeongyeon Shin, Yaping Zhao, et al.
Small Science (2024)
Open Access | Times Cited: 2
The Impact of Combined Chemotherapy and Intra-Tumoural Injection of Phosphorus-32 Microparticles on Vascularity in Locally Advanced Pancreatic Carcinoma
Amanda Lim, Joshua Zobel, Madison Bills, et al.
Cancers (2024) Vol. 16, Iss. 19, pp. 3412-3412
Open Access | Times Cited: 1
Alleviating tumor hypoxia and immunosuppression via sononeoperfusion: A new Ally for potentiating anti-PD-L1 blockade of solid tumor
Guoliang Yang, Hui Li, Jiabei Yin, et al.
Ultrasonics Sonochemistry (2024), pp. 107115-107115
Open Access | Times Cited: 1
The influence of endothelial metabolic reprogramming on the tumor microenvironment
Kelby M. Kane, Deanna N. Edwards, Jin Chen
Oncogene (2024)
Open Access | Times Cited: 1
Prognostic value of the tumor-to-liver density ratio in patients with metastatic colorectal cancer treated with bevacizumab-based chemotherapy. A post-hoc study of the STIC-AVASTIN trial
Thibault Mazard, Caroline Mollévi, Evelyne M. Loyer, et al.
Cancer Imaging (2024) Vol. 24, Iss. 1
Open Access
Exploring potential predictive biomarkers through historical perspectives on the evolution of systemic therapies into the emergence of neoadjuvant therapy for the treatment of hepatocellular carcinoma
Chuanlei Wang, Wei Feng, Xiaodong Sun, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Lenvatinib radiofrequency ablation sequential therapy offers survival benefits for patients with unresectable hepatocellular carcinoma at intermediate stage and the liver reserve of Child–Pugh A category: A multicenter study
Ying Zhang, Kazushi Numata, Kento Imajo, et al.
Hepatology Research (2024) Vol. 54, Iss. 12, pp. 1174-1192
Closed Access
Page 1 - Next Page

Scroll to top